Corcione A, Ottonello L, Tortolina G, Facchetti P, Airoldi I, Guglielmino R, Dadati P, Truini M, Sozzani S, Dallegri F, Pistoia V
Laboratory of Oncology, G. Gaslini Institute, Genoa, Italy.
J Natl Cancer Inst. 2000 Apr 19;92(8):628-35. doi: 10.1093/jnci/92.8.628.
Follicular center lymphoma displays widespread lymph node involvement at diagnosis. The chemoattractants that control the locomotion of follicular center lymphoma B cells have not been established. Stromal cell-derived factor-1 (SDF-1) is a CXC-class chemokine that enhances the migration of normal human B cells and is expressed in peripheral lymphoid tissues. Here we have investigated 1) whether SDF-1 stimulates the in vitro locomotion of follicular center lymphoma B cells and of their presumed normal counterparts (i. e., germinal center B cells) and 2) whether the same cells express SDF-1 transcripts.
B cells were purified by immunomagnetic bead manipulation. Messenger RNA was detected by reverse transcription-polymerase chain reaction. Migration was assessed by the filter and collagen invasion assays. All P values were two sided.
Follicular center lymphoma B lymphocytes showed a statistically significant migratory response to 300 ng/mL SDF-1, both in the filter and in the collagen assays (P =.002 for each). Such response was mediated by the SDF-1 receptor, CXCR4. CD40 monoclonal antibody (MAb) and tonsillar germinal center B cells treated with CD40 MAb and recombinant interleukin 4, but not freshly isolated, migrated statistically significantly faster in the presence than in the absence of SDF-1 (P =.002 in both filter and collagen assays). Freshly isolated follicular center lymphoma and germinal center B cells expressed SDF-1 transcripts.
This study shows that SDF-1 substantially enhances the migration of follicular center lymphoma B cells but not the migration of freshly purified germinal center B cells. This difference may be related to the extended survival of follicular center lymphoma versus germinal center B cells. SDF-1 produced in follicular center lymphoma lymph nodes may play a role in the local dissemination of tumor cells.
滤泡中心淋巴瘤在诊断时表现为广泛的淋巴结受累。控制滤泡中心淋巴瘤B细胞运动的趋化因子尚未明确。基质细胞衍生因子-1(SDF-1)是一种CXC类趋化因子,可增强正常人B细胞的迁移,并在外周淋巴组织中表达。在此,我们研究了:1)SDF-1是否刺激滤泡中心淋巴瘤B细胞及其假定的正常对应细胞(即生发中心B细胞)的体外运动;2)这些细胞是否表达SDF-1转录本。
通过免疫磁珠操作纯化B细胞。通过逆转录-聚合酶链反应检测信使RNA。通过滤膜和胶原侵袭试验评估迁移情况。所有P值均为双侧。
在滤膜试验和胶原试验中,滤泡中心淋巴瘤B淋巴细胞对300 ng/mL SDF-1均表现出具有统计学意义的迁移反应(每项试验P = 0.002)。这种反应由SDF-1受体CXCR4介导。CD40单克隆抗体(MAb)以及用CD40 MAb和重组白细胞介素4处理过的扁桃体生发中心B细胞,而非新鲜分离的细胞,在有SDF-1存在时的迁移速度在统计学上显著快于无SDF-1时(滤膜试验和胶原试验中P均为0.002)。新鲜分离的滤泡中心淋巴瘤和生发中心B细胞表达SDF-1转录本。
本研究表明,SDF-1可显著增强滤泡中心淋巴瘤B细胞的迁移,但对新鲜纯化的生发中心B细胞的迁移无增强作用。这种差异可能与滤泡中心淋巴瘤细胞与生发中心B细胞的存活时间延长有关。滤泡中心淋巴瘤淋巴结中产生的SDF-1可能在肿瘤细胞的局部播散中起作用。